デフォルト表紙
市場調査レポート
商品コード
1701125

バイオインフォマティクスの市場規模、シェア、成長分析:製品別、用途別、分野別、地域別 - 産業予測 2025~2032年

Bioinformatics Market Size, Share, and Growth Analysis, By Product (Knowledge Management Tools, Bioinformatics Platforms), By Application (Genomics, Chemoinformatics & Drug Design), By Sector, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオインフォマティクスの市場規模、シェア、成長分析:製品別、用途別、分野別、地域別 - 産業予測 2025~2032年
出版日: 2025年04月04日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオインフォマティクスの世界市場規模は2023年に116億米ドルと評価され、2024年の131億7,000万米ドルから2032年には362億6,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは13.5%で成長する見通しです。

バイオインフォマティクス市場は、主に医薬品研究開発への民間および公的投資の拡大により、予測期間中に大きく成長する見込みです。RasMol、AUTODOCK、Bioclipseのようなユーザーフレンドリーなバイオインフォマティクスソフトウェアは、データアクセシビリティと解析を強化し、研究開発イニシアチブに不可欠なものとなっています。様々な「-omics」分野で研究プログラムが拡大するにつれて、洗練されたデータストレージと分析ソリューションに対する需要は増加する傾向にあります。特筆すべきは、スタンフォード医科大学が報告したようなDNA配列決定技術の進歩により、ヒトゲノムを約8時間で解読できるようになり、ゲノム解析の需要がさらに高まっていることです。この急増は、遺伝性疾患、化学予防、発がん性物質研究に関連する複雑な課題に対処する上でのバイオインフォマティクスの重要性を強調し、この分野が現代医療において重要な役割を担っていることを強調しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 規制分析
  • 技術分析
  • ケーススタディ

バイオインフォマティクス市場規模:製品・サービス別

  • 市場概要
  • ナレッジマネジメントツール
    • 汎用的な知識管理ツール
    • 専門的な知識管理ツール
  • バイオインフォマティクスプラットフォーム
    • データ分析プラットフォーム
    • 構造および機能解析プラットフォーム
    • その他のバイオインフォマティクスプラットフォーム
  • バイオインフォマティクスサービス
    • シーケンシングサービス
    • データ分析サービス
    • 創薬サービス
    • 遺伝子発現差解析サービス
    • データベースおよび管理サービス
    • その他のバイオインフォマティクスサービス

バイオインフォマティクス市場規模:用途別

  • 市場概要
  • ゲノミクス
  • ケモインフォマティクスと医薬品設計
  • プロテオミクス
  • トランスクリプトミクス
  • メタボロミクス
  • その他の用途

バイオインフォマティクス市場規模:分野別

  • 市場概要
  • 医療バイオテクノロジー
    • 医薬品の発見と開発
    • 臨床診断と個別化医療
    • 生殖保健
  • 動物バイオテクノロジー
  • 植物バイオテクノロジー
  • 環境バイオテクノロジー
  • 法医学バイオテクノロジー
  • その他のセクター

バイオインフォマティクス市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022~2024年)

主要企業プロファイル

  • Illumina Inc.(US)
  • Thermo Fisher Scientific Inc.(US)
  • Qiagen N.V.(Netherlands)
  • Agilent Technologies Inc.(US)
  • BGI Group(China)
  • PerkinElmer Inc.(US)
  • Eurofins Scientific SE(Europe)
  • Waters Corporation(US)
  • DNAnexus Inc.(US)
  • Sophia Genetics SA(Switzerland)
  • Partek Incorporated(US)
  • Gene Codes Corporation(US)
  • Dassault Systemes SE(France)
  • Biomax Informatics AG(Germany)
  • Bruker Corporation(US)
  • Macrogen Inc.(South Korea)

結論と提言

目次
Product Code: SQMIG35H2059

Global Bioinformatics Market size was valued at USD 11.6 billion in 2023 and is poised to grow from USD 13.17 billion in 2024 to USD 36.26 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The bioinformatics market is poised for significant growth during the forecast period, primarily driven by escalating private and public investments in drug research and development. User-friendly bioinformatics software such as RasMol, AUTODOCK, and Bioclipse enhance data accessibility and analysis, making them integral to R&D initiatives. As research programs expand across various '-omics' fields, the demand for sophisticated data storage and analytical solutions is set to increase. Notably, advancements in DNA sequencing technologies, like those reported by Stanford Medicine, can now decode the human genome in about eight hours, further propelling the demand for genomic analysis. This surge emphasizes the importance of bioinformatics in addressing complex challenges related to genetic diseases, chemoprevention, and carcinogen research, underscoring the sector's critical role in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Market Segments Analysis

Global Bioinformatics Market is segmented by Product, Application, Sector and region. Based on Product, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics and Other Applications. Based on Sector, the market is segmented into Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Other Sectors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioinformatics Market

The expansion of personalized medicine is a significant catalyst for the global bioinformatics market. As healthcare shifts toward tailored treatment approaches grounded in individual genetic profiles, there is a rising necessity for bioinformatics tools designed to process and analyze extensive genetic datasets. This escalating demand is propelling the utilization of bioinformatics across pharmaceutical sectors, enhancing diagnostics, evaluation processes, and treatment alternatives. Consequently, the integration of advanced bioinformatics solutions is becoming essential to leverage genetic insights effectively, ultimately fostering more precise and personalized healthcare outcomes. This trend highlights the pivotal role bioinformatics plays in the future of medicine.

Restraints in the Global Bioinformatics Market

The Global Bioinformatics market faces significant challenges due to the high expenses linked to software, hardware, and services. The substantial investment required for bioinformatics systems can pose a financial burden, particularly for smaller research institutions and companies, especially in developing regions with limited market expansion potential. These costs can act as a barrier to entry, inhibiting the adoption of innovative bioinformatics solutions and restricting the overall growth of the market. Consequently, organizations may struggle to access the necessary tools and technologies that facilitate advancements in research and development within the biosciences sector.

Market Trends of the Global Bioinformatics Market

The Global Bioinformatics market is increasingly driven by the integration of artificial intelligence (AI) and machine learning (ML), positioning these technologies as vital components of bioinformatics solutions. These AI-powered tools enhance data analysis capabilities, allowing for expedited and precise interpretation of complex biological datasets. The trend signifies a shift towards improved predictive modeling, more refined pattern recognition, and sophisticated decision-making strategies across various applications, including drug discovery, genomics, and personalized medicine. As the demand for faster and more reliable insights into biological phenomena grows, the bioinformatics sector is poised for robust growth, fostering innovation and collaboration within the life sciences industry.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Regulatory Analysis
  • Technology Analysis
  • Case Studies

Global Bioinformatics Market Size by Product & Service & CAGR (2025-2032)

  • Market Overview
  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Bioinformatics Platforms
    • Data Analysis Platforms
    • Structural & Functional Analysis Platforms
    • Other Bioinformatics Platforms
  • Bioinformatics Services
    • Sequencing Services
    • Data Analysis Services
    • Drug Discovery Services
    • Differential Gene Expression Analysis Services
    • Database And Management Services
    • Other Bioinformatics Services

Global Bioinformatics Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Genomics
  • Chemoinformatics & Drug Design
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Other Applications

Global Bioinformatics Market Size by Sector & CAGR (2025-2032)

  • Market Overview
  • Medical Biotechnology
    • Drug Discovery & Development
    • Clinical Diagnostics & Personalized Medicine
    • Reproductive Health
  • Animal Biotechnology
  • Plant Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Other Sectors

Global Bioinformatics Market Size & CAGR (2025-2032)

  • North America (Product & Service, Application, Sector)
    • US
    • Canada
  • Europe (Product & Service, Application, Sector)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product & Service, Application, Sector)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product & Service, Application, Sector)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product & Service, Application, Sector)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Illumina Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Europe)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DNAnexus Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sophia Genetics SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Partek Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gene Codes Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dassault Systemes SE (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomax Informatics AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Macrogen Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations